Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 31.86%22.47B | 32.79%38.3B | 25.59%17.04B | 17.03%28.84B | 15.58%13.57B | 16.11%24.64B | -0.56%11.74B | -10.67%21.23B | 22.82%11.81B | 5.53%23.76B |
| Special items of operating revenue | 2.26%222.1M | 3.44%423.58M | 12.55%217.18M | 20.27%409.49M | 47.53%192.96M | -1.16%340.47M | 8.49%130.79M | 43.94%344.45M | -13.32%120.55M | -37.98%239.3M |
| Operating income | 31.49%22.7B | 32.38%38.72B | 25.41%17.26B | 17.08%29.25B | 15.93%13.76B | 15.83%24.98B | -0.47%11.87B | -10.12%21.57B | 22.30%11.93B | 4.80%24B |
| Operating expenses | -30.82%-19.77B | -29.66%-33.5B | -24.70%-15.11B | -18.63%-25.84B | -21.66%-12.12B | 1.90%-21.78B | 5.59%-9.96B | -5.44%-22.2B | -26.39%-10.55B | -9.72%-21.06B |
| Gross profit | 36.22%2.93B | 52.97%5.22B | 30.58%2.15B | 6.52%3.41B | -13.88%1.65B | 605.72%3.2B | 38.77%1.91B | -121.53%-633.53M | -1.98%1.38B | -20.68%2.94B |
| Selling expenses | 0.19%-238.98M | -20.00%-606.82M | 10.48%-239.42M | 18.95%-505.7M | -12.52%-267.46M | 2.15%-623.91M | -3.89%-237.7M | 5.65%-637.64M | -13.18%-228.8M | -11.90%-675.86M |
| Administrative expenses | -15.18%-758.39M | -8.55%-1.69B | -4.89%-658.45M | -20.51%-1.56B | -25.95%-627.75M | 17.41%-1.3B | 4.33%-498.4M | -20.21%-1.57B | -17.84%-520.94M | 21.87%-1.3B |
| Research and development expenses | -4.55%-432.06M | -15.36%-1.15B | -17.82%-413.24M | -37.43%-998.63M | -21.50%-350.76M | -8.37%-726.64M | -2.77%-288.69M | 31.35%-670.53M | -0.03%-280.9M | -42.06%-976.71M |
| Profit from asset sales | 5.95%2.41M | -10.98%2.59M | 955.37%2.27M | 4.41%2.91M | -28.58%215.41K | -95.51%2.79M | -97.47%301.59K | 970.96%62.02M | 5,625.71%11.91M | 9.27%5.79M |
| Revaluation surplus | ---5.83M | 217.48%10M | ---- | 298.88%3.15M | ---- | --789.66K | ---- | ---- | ---- | --217.41K |
| -Changes in the fair value of other assets | ---5.83M | 217.48%10M | ---- | 298.88%3.15M | ---- | --789.66K | ---- | ---- | ---- | --217.41K |
| Impairment and provision | -336.89%-289.76M | -21.99%396.56M | 65.49%-66.32M | 285.80%508.34M | 71.48%-192.21M | 69.64%-273.59M | -128.66%-673.96M | -534.62%-901.13M | -4.53%-294.74M | 72.72%-141.99M |
| -Other impairment is provision | -336.89%-289.76M | -21.99%396.56M | 65.49%-66.32M | 285.80%508.34M | 71.48%-192.21M | 69.64%-273.59M | -128.66%-673.96M | -534.62%-901.13M | -4.53%-294.74M | 72.72%-141.99M |
| Operating interest expense | 65.66%-2.33M | 23.43%-12.06M | -111.39%-6.77M | -1.98%-15.76M | 25.25%-3.2M | -77.43%-15.45M | 2.01%-4.29M | 9.30%-8.71M | 8.04%-4.37M | 33.46%-9.6M |
| Special items of operating profit | 88.41%261.71M | -34.34%323.88M | 100.05%138.9M | 163.03%493.25M | 64.99%69.43M | -23.16%187.53M | -45.97%42.08M | -55.92%244.04M | 31.30%77.89M | 326.94%553.64M |
| Adjustment items of operating profit | -52.18%106.71K | ---- | --223.14K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 62.67%1.37B | 98.21%2.27B | 327.84%841.35M | 293.20%1.14B | 8.55%196.65M | 106.80%290.81M | 127.75%181.16M | -1,987.97%-4.28B | -59.68%79.54M | 1.75%226.52M |
| Financing cost | 0.43%-145.85M | 19.28%-241.87M | -60.43%-146.48M | -121.79%-299.65M | -17.16%-91.3M | -867.80%-135.11M | -553.48%-77.93M | 92.53%-13.96M | 88.01%-11.93M | -151.96%-186.92M |
| Adjustment items of earning before tax | 206.14%4.66M | 93.03%-5.22M | -106.50%-4.39M | -249.37%-74.8M | 218.35%67.47M | -44.61%50.07M | 3.19%21.19M | 142.02%90.41M | 1,890.64%20.54M | -45.63%37.35M |
| Earning before tax | 77.77%1.23B | 162.60%2.02B | 299.55%690.48M | 273.71%769.01M | 38.89%172.82M | 104.90%205.78M | 41.14%124.42M | -5,557.88%-4.2B | -10.86%88.15M | -64.56%76.96M |
| Tax | -14.52%-171.1M | -95.84%-300.86M | -118.38%-149.41M | -101.21%-153.62M | -8.89%-68.42M | -176.81%-76.35M | -45.46%-62.83M | 263.21%99.4M | 30.02%-43.19M | 39.05%-60.9M |
| After-tax profit from continuing operations | 95.23%1.06B | 172.03%1.72B | 418.27%541.07M | 388.10%631.74M | 69.49%104.4M | 103.16%129.43M | 37.00%61.6M | -25,642.48%-4.1B | 20.97%44.96M | -86.30%16.06M |
| After-tax profit from non-continuing business | ---- | ---- | ---- | ---16.35M | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning after tax | 95.23%1.06B | 179.26%1.72B | 418.27%541.07M | 375.46%615.38M | 69.49%104.4M | 103.16%129.43M | 37.00%61.6M | -25,642.48%-4.1B | 20.97%44.96M | -86.30%16.06M |
| Minority profit | -70.44%5.44M | -18.88%32.95M | -5.66%18.41M | 31.94%40.62M | 99.86%19.51M | -25.95%30.79M | -6.94%9.76M | 78.19%41.58M | 31.10%10.49M | 111.33%23.34M |
| Profit attributable to shareholders | 101.06%1.05B | 193.27%1.69B | 515.70%522.67M | 482.69%574.76M | 63.77%84.89M | 102.38%98.64M | 50.37%51.84M | -56,797.56%-4.14B | 18.19%34.47M | -106.86%-7.28M |
| Basic earnings per share | 104.35%0.47 | 141.94%0.75 | 360.00%0.23 | 434.48%0.31 | 66.67%0.05 | 102.39%0.058 | 50.00%0.03 | -60,575.00%-2.427 | 0.00%0.02 | -106.45%-0.004 |
| Diluted earnings per share | 104.35%0.47 | 141.94%0.75 | 360.00%0.23 | 434.48%0.31 | 66.67%0.05 | 102.39%0.058 | 50.00%0.03 | -60,575.00%-2.427 | 0.00%0.02 | -106.45%-0.004 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | Dahua Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.